TechOwkin agrees to license AI platform and patient data to Servier, Pulse2.com reports
Pulse2.com says the agreement aims to support Servier's cancer research and accelerate the study of hard-to-treat cancers.
TLDR
Pulse2.com reports that Owkin has entered an agreement to license K Pro, its AI Scientist platform, along with multimodal patient data to Servier. The publisher describes the deal as supporting Servier's oncology research, with the goal of speeding up the study of hard-to-treat cancers.
Combined views
62
1 post, first seen 5d ago
Owkin agrees to license AI platform and patient data to Servier, Pulse2.com reports
Pulse2.com says the agreement aims to support Servier's cancer research and accelerate the study of hard-to-treat cancers.
TLDR
Pulse2.com reports that Owkin has entered an agreement to license K Pro, its AI Scientist platform, along with multimodal patient data to Servier. The publisher describes the deal as supporting Servier's oncology research, with the goal of speeding up the study of hard-to-treat cancers.